Food and Drug Administration warns of toxic... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Drug injuries may result from rushed pharmacists By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 03, 2026 Read More
Makers of Abilify face pharmaceutical litigation over... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration reviewing policies for... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration concerned over study... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Popular anti-nausea medicine linked to drug injuries By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Prince’s death shines light on fentanyl’s drug... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Have you suffered from drug injuries in... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Pharmaceutical litigation could follow EpiPen recall By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Cholesterol-lowering statins linked to drug injuries in... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Johnson & Johnson allegedly hid Risperdal related... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 07, 2026 Read More
Why did the Food and Drug Administration... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 07, 2026 Read More